Mobile

A study to evaluate whether a new inhaled medicine (combination of beclometasone plus formoterol plus glycopyrronium) works as well as a combination of licensed medicines (combination of fluticasone p...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-001487-35

A study to evaluate whether a new inhaled medicine (combination of beclometasone plus formoterol plus glycopyrronium) works as well as a combination of licensed medicines (combination of fluticasone plus vilanterol and tiotropium) in patient with chronic obstructive pulmonary disease

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate the non-inferiority of CHF 5993 pMDI versus fixed combination of fluticasone furoate/vilanterol plus tiotropium in terms of quality of life (change from baseline in the St. George’s Respiratory Questionnaire [SGRQ] total score after 26 weeks of treatment).

Critère d'inclusion

  • Chronic Obstructive Pulmonary Disease

Liens